title: Peginterferon and ribavirin for hepatitis C.
authors: Chaker
authors: C
authors: Ben Salem
authors: Houssem
authors: H
authors: Hmouda
authors: Kamel
authors: K
authors: Bouraoui
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D010195:Pancreatitis / Q000139:chemically induced*; D011092:Polyethylene Glycols / Q000009:adverse effects; D011994:Recombinant Proteins; D012254:Ribavirin / Q000009:adverse effects*
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin